Linked Life Data

19706860

Source:http://linkedlifedata.com/resource/pubmed/id/19706860

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-8-26
pubmed:abstractText
Hormonal therapy (HT) when added to radiation therapy (RT) for treating unfavorable-risk prostate cancer leads to an increase in survival except possibly in men with moderate to severe comorbidity. However, it is unknown which comorbid conditions eliminate this survival benefit.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1538-3598
pubmed:author
pubmed:issnType
Electronic
pubmed:day
26
pubmed:volume
302
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
866-73
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:19706860-Aged, pubmed-meshheading:19706860-Androgen Antagonists, pubmed-meshheading:19706860-Antineoplastic Agents, Hormonal, pubmed-meshheading:19706860-Brachytherapy, pubmed-meshheading:19706860-Comorbidity, pubmed-meshheading:19706860-Coronary Artery Disease, pubmed-meshheading:19706860-Diabetes Mellitus, pubmed-meshheading:19706860-Gonadotropin-Releasing Hormone, pubmed-meshheading:19706860-Heart Failure, pubmed-meshheading:19706860-Humans, pubmed-meshheading:19706860-Hypercholesterolemia, pubmed-meshheading:19706860-Hypertension, pubmed-meshheading:19706860-Kaplan-Meier Estimate, pubmed-meshheading:19706860-Male, pubmed-meshheading:19706860-Myocardial Infarction, pubmed-meshheading:19706860-Neoadjuvant Therapy, pubmed-meshheading:19706860-Proportional Hazards Models, pubmed-meshheading:19706860-Prostatic Neoplasms, pubmed-meshheading:19706860-Risk Factors, pubmed-meshheading:19706860-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
pubmed:affiliation
Harvard Radiation Oncology Program, Brigham & Women's Hospital-Dana-Farber Cancer Institute, 75 Francis St, ASB1 L2, Boston, MA 02115, USA. ananda@partners.org
pubmed:publicationType
Journal Article